Simulations Plus Stock: Reliance On Consulting And Acquisitions Creates Doubts (SLP)
Jonathan Kitchen Simulations Plus (NASDAQ:SLP) is a software and services provider that is benefiting from the growing use of computational tools in drug discovery. While Simulations Plus has a strong business, its valuation is high given modest growth prospects and a heavy reliance on acquisitions and consulting revenue. I would not expect a meaningful correction…